These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 2198889)

  • 1. Evaluation of a new polyamide membrane (Polyflux 130) in high-flux dialysis.
    Schaefer RM; Gilge U; Goehl H; Heidland A
    Blood Purif; 1990; 8(1):23-31. PubMed ID: 2198889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
    Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
    Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemofiltration and the middle molecule.
    Henderson LW
    Blood Purif; 1999; 17(4):175-7. PubMed ID: 10494018
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of beta 2-microglobulin by hemodialysis and hemofiltration: a four year follow up.
    Schiffl H; D'Agostini B; Held E
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1223-32. PubMed ID: 1457695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
    Schaefer RM; Hörl WH; Kokot K; Heidland A
    Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
    Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
    Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of oxidative and antioxidative capacity during high-flux hemodialysis using two different membranes.
    Schönermarck U; Dengler C; Ebeling F; Heydenreich M; Hillebrand GF; Samtleben W
    Clin Nephrol; 2006 Nov; 66(5):357-63. PubMed ID: 17140165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.
    Küchle C; Fricke H; Held E; Schiffl H
    Am J Nephrol; 1996; 16(6):484-8. PubMed ID: 8955759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of a new polymeric membrane for use in renal replacement therapy.
    Hoenich NA; Katopodis KP
    Biomaterials; 2002 Sep; 23(18):3853-8. PubMed ID: 12164189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of 131I-beta2 microglobulin in hemodialysis patients: assessment using total body counting.
    Chanard J; Caudwell V; Valeire J; Vincent C; Randoux C; Wuillai A; Wynckel A
    Artif Organs; 1998 Jul; 22(7):574-80. PubMed ID: 9684694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures.
    Goldman M; Lagmiche M; Dhaene M; Amraoui Z; Thayse C; Vanherweghem JL
    Int J Artif Organs; 1989 Jun; 12(6):373-8. PubMed ID: 2674020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical performance of a new high-flux synthetic membrane.
    Hoenich NA; Stamp S
    Am J Kidney Dis; 2000 Aug; 36(2):345-52. PubMed ID: 10922313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microdomain-structured synthetic high-flux hollow-fiber membrane for renal replacement therapy.
    Hoenich NA; Stamp S; Roberts SJ
    ASAIO J; 2000; 46(1):70-5. PubMed ID: 10667721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.